These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38413123)

  • 1. Why do patients with DR-TB do not complete their treatment? Findings of a qualitative study from Pakistan.
    Abubakar M; Ullah M; Shaheen MA; Abdullah O
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Better to Die Than Take These Medicines": A Community-Based Qualitative Study on the Determinants of Treatment Loss-to-Follow-Up in Tuberculosis Patients in District Faridabad, Haryana, India.
    Khaitan A; Rai SK; Krishnan A; Gupta SK; Kant S; Khilnani GC
    Cureus; 2022 May; 14(5):e25030. PubMed ID: 35591891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient and Provider Reported Reasons for Lost to Follow Up in MDRTB Treatment: A Qualitative Study from a Drug Resistant TB Centre in India.
    Deshmukh RD; Dhande DJ; Sachdeva KS; Sreenivas A; Kumar AM; Satyanarayana S; Parmar M; Moonan PK; Lo TQ
    PLoS One; 2015; 10(8):e0135802. PubMed ID: 26301748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
    Jakasania A; Shringarpure K; Kapadia D; Sharma R; Mehta K; Prajapati A; Kathirvel S
    BMC Infect Dis; 2020 Dec; 20(1):918. PubMed ID: 33267826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.
    Massud A; Khan AH; Syed Sulaiman SA; Ahmad N; Shafqat M; Ming LC
    PLoS One; 2023; 18(8):e0287966. PubMed ID: 37561810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance profile of Mycobacterium tuberculosis and predictors associated with the development of drug resistance.
    Hameed S; Ahmad SR; Rahman MAU; Nazir H; Ullah I
    J Glob Antimicrob Resist; 2019 Sep; 18():155-159. PubMed ID: 30910744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects.
    Soedarsono S; Mertaniasih NM; Kusmiati T; Permatasari A; Juliasih NN; Hadi C; Alfian IN
    BMC Pulm Med; 2021 Nov; 21(1):360. PubMed ID: 34758794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Factors Associated with Unfavorable Outcomes among Drug-Resistant TB Patients: A 6-Year Retrospective Study from Pakistan.
    Khan FU; Rehman AU; Khan FU; Hayat K; Khan A; Ahmad N; Chang J; Malik UR; Fang Y
    Int J Environ Res Public Health; 2022 Jan; 19(3):. PubMed ID: 35162598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation in missed doses and reasons for discontinuation of anti-tuberculosis drugs during hospital treatment for drug-resistant tuberculosis in South Africa.
    Pietersen E; Anderson K; Cox H; Dheda K; Bian A; Shepherd BE; Sterling TR; Warren RM; van der Heijden YF
    PLoS One; 2023; 18(2):e0281097. PubMed ID: 36780443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia: a retrospective follow-up study.
    Kassa GM; Teferra AS; Wolde HF; Muluneh AG; Merid MW
    BMC Infect Dis; 2019 Sep; 19(1):817. PubMed ID: 31533661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
    McNally TW; de Wildt G; Meza G; Wiskin CMD
    BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring local realities: Perceptions and experiences of healthcare workers on the management and control of drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Yimer SA; Manyazewal T; Gradmann C
    PLoS One; 2019; 14(11):e0224277. PubMed ID: 31721767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What Makes People With Chronic Illnesses Discontinue Treatment? A Practice Theory Informed Analysis of Adherence to Treatment among Patients With Drug-Resistant Tuberculosis in Pakistan.
    Abbas S; Kermode M; Khan MD; Denholm J; Adetunji H; Kane S
    Int J Health Policy Manag; 2023; 12():6576. PubMed ID: 37579474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients.
    Atif M; Bashir A; Ahmad N; Fatima RK; Saba S; Scahill S
    BMC Infect Dis; 2017 Sep; 17(1):655. PubMed ID: 28962599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysis.
    Pai H; Ndjeka N; Mbuagbaw L; Kaniga K; Birmingham E; Mao G; Alquier L; Davis K; Bodard A; Williams A; Van Tongel M; Thoret-Bauchet F; Omar SV; Bakare N
    BMC Infect Dis; 2022 Nov; 22(1):870. PubMed ID: 36414938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lived experiences of patients and families with decentralised drug-resistant tuberculosis care in the Eastern Cape, South Africa.
    Iruedo JO; Pather MK
    Afr J Prim Health Care Fam Med; 2023 Dec; 15(1):e1-e16. PubMed ID: 38197684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Shorter Treatment Regimen in Multidrug-Resistant Tuberculosis Patients in Pakistan: A Multicenter Retrospective Record Review.
    Wahid A; Ahmad N; Ghafoor A; Latif A; Saleem F; Khan S; Atif M; Iqbal Q
    Am J Trop Med Hyg; 2021 Mar; 104(5):1784-1791. PubMed ID: 33724924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging the gap between policy and practice: a qualitative analysis of providers' field experiences tinkering with directly observed therapy in patients with drug-resistant tuberculosis in Addis Ababa, Ethiopia.
    Mussie KM; Gradmann C; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e035272. PubMed ID: 32554739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring health care providers' engagement in prevention and management of multidrug resistant Tuberculosis and its factors in Hadiya Zone health care facilities: qualitative study.
    Lajore BA; Aweke YH; Ayanto SY; Ayele M
    BMC Health Serv Res; 2024 Apr; 24(1):542. PubMed ID: 38678263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.